Evidence map›Paper›PMID 38769918›Full record

ArticleMolecular reproduction and development2024

Loss of KANSL3 leads to defective inner cell mass and early embryonic lethality.

Ashmita Chander, Jesse Mager

Abstract read
In one paragraph

Article in Molecular reproduction and development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Microtubule Minus-End Binding Proteins in Cancer: Advances.Diagnostics (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ashmita ChanderDepartment of Veterinary & Animal Sciences, University of Massachusetts Amherst, Amherst, Massachusetts, USA.
Jesse MagerDepartment of Veterinary & Animal Sciences, University of Massachusetts Amherst, Amherst, Massachusetts, USA.

Funding

Streamline assessment of early lethal phenotypes in the mouseR01HD083311 · NICHD · UNIVERSITY OF MASSACHUSETTS AMHERST · PI MAGER, JESSE · 2015 to 2024
$6.5M
NICHD NIH HHS R01 HD083311
6 · The paper itself

Abstract

e-Lysine acetylation is a prominent histone mark found at transcriptionally active loci. Among many lysine acetyl transferases, nonspecific lethal complex (NSL) members are known to mediate the modification of histone H4. In addition to histone modifications, the KAT8 regulatory complex subunit 3 gene (Kansl3), a core member of NSL complex, has been shown to be involved in several other cellular processes such as mitosis and mitochondrial activity. Although functional studies have been performed on NSL complex members, none of the four core proteins, including Kansl3, have been studied during early mouse development. Here we show that homozygous knockout Kansl3 embryos are lethal at peri-implantation stages, failing to hatch out of the zona pellucida. When the zona pellucida is removed in vitro, Kansl3 null embryos form an abnormal outgrowth with significantly disrupted inner cell mass (ICM) morphology. We document lineage-specific defects at the blastocyst stage with significantly reduced ICM cell number but no difference in trophectoderm cell numbers. Both epiblast and primitive endoderm lineages are altered with reduced cell numbers in null mutants. These results show that Kansl3 is indispensable during early mouse embryonic development and with defects in both ICM and trophectoderm lineages.

Indexed as

Embryonic DevelopmentAnimalsBlastocystBlastocyst Inner Cell MassEmbryo LossFemaleHistone AcetyltransferasesMiceMice, KnockoutHistone Acetyltransferasesblastocystepigenetic regulationhistone modificationinner cell massKansl3preimplantation

Identifiers

PMID38769918
PMCPMC11244731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.